11. Associations of anticoagulant use with outcome in newly diagnosed glioblastoma. (September 2018) Authors: Le Rhun, Emilie; Genbrugge, Els; Stupp, Roger; Chinot, Olivier L.; Nabors, L. Burt; Cloughesy, Timothy; Reardon, David A.; Wick, Wolfgang; Gorlia, Thierry; Weller, Michael Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. ATIM-02. DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 & TOCA FC TREATMENT. Issue 11 (6th November 2017) Authors: Cloughesy, Timothy; Landolfi, Joseph; Vogelbaum, Michael; Ostertag, Derek; Elder, Bradley; Carter, Bob; Chen, Clark; Kalkanis, Steven; Lai, Albert; Mikkelsen, Tom; Nghiemphu, Phioanh; Piccioni, David; Accomando, William; Diago, Oscar; Hogan, Daniel; Jolly, Douglas; Wood, Katie; Yang, Liqiang; Gru... Journal: Neuro-oncology Issue: Volume 19:Issue 11(2017)supplement 6 Page Start: vi26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. ATIM-09. CLINICAL TRIAL IN PROGRESS: A STUDY OF NEOADJUVANT AND ADJUVANT VB-111 FOR TREATMENT OF RECURRENT GBM. (11th November 2019) Authors: Cloughesy, Timothy; Butowski, Nicholas; Harats, Dror; Rachmilewitz Minei, Tamar; Wen, Patrick Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL. (5th November 2018) Authors: Prins, Robert; Mochizuki, Aaron; Orpilla, Joey; Lee, Alexander; Davidson, Tom; Gaffey, Sarah; Sanders, Catherine; Rytlewski, Julie; Ellingson, Benjamin; Li, Gang; Yong, William; Clarke, Jennifer; Arrillaga-Romany, Isabel; Colman, Howard; Reardon, David; Kaley, Thomas; de Groot, John; Liau, Linda;... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. ATIM-16. VALIDATION OF RESPONSE TO NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA. (11th November 2019) Authors: Chow, Frances; Mochizuki, Aaron; Lee, Alexander; Galvez, Mildred; Orpilla, Joey; Everson, Richard; Liau, Linda; Cloughesy, Timothy; Prins, Robert Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. ATIM-19. RESULTS OF THE GLOBE STUDY: A PHASE 3, RANDOMIZED, CONTROLLED, DOUBLE-ARM, OPEN-LABEL, MULTI-CENTER STUDY OF VB-111 COMBINED WITH BEVACIZUMAB VS. BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (5th November 2018) Authors: Cloughesy, Timothy; Brenner, Andrew J; Butowski, Nicholas; Cohen, Yael C; Lowenton-Spier, Noa; Wen, Patrick Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (5th November 2018) Authors: Zadeh, Gelareh; Lang, Frederick; Daras, Mariza; Cloughesy, Timothy; Colman, Howard; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael; Groves, Morris; Nassiri, Farshad; Frederick, L Sue; Gammon, Karen; Fulling, Sheila; Rowland, Kari Anne; Mitchell, Erin; Ewald, Brett; Tufaro, Frank; Peterkin, ... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA. (5th November 2018) Authors: Orpilla, Joey; Mochizuki, Aaron; Reynoso, Jeremy; Akkad, Neha; Lee, Alexander; Davidson, Tom; Liau, Linda; Cloughesy, Timothy; Prins, Robert Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. ATIM-29. A PHASE 1 STUDY OF PF-06840003, AN ORAL INDOLE 2, 3-DIOXYGENASE 1 (IDO1) INHIBITOR IN PATIENTS WITH MALIGNANT GLIOMAS. (6th November 2017) Authors: Reardon, David; Desjardins, Annick; Rixe, Olivier; Cloughesy, Timothy; Alekar, Shilpa; Gamelin, Erick; Williams, Jason; Meissen, John; Taylor, Carrie; Lassman, Andrew Journal: Neuro-oncology Issue: Volume 19(2017)Supplement 6 Page Start: vi32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (11th November 2019) Authors: Aiken, Robert; Chen, Clark; Cloughesy, Timothy; Colman, Howard; Daras, Mariza; Groves, Morris; Khagi, Simon; Kumthekar, Priya; Lang, Frederick; Nassiri, Farshad; Ong, Shirley; Ramakrishna, Rohan; Sonabend, Adam; Vogelbaum, Michael; Zadeh, Gelareh; Agensky, Laura; Bidwell, Carin; Watkins, Barry; T... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗